Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 26, 2022
Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepamPablo Zubiaur, Laura Figueiredo-Tor, Gonzalo Villapalos-García, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 31, 2020
Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteersPablo Zubiaur, Paula Soria-Chacartegui, Dora Koller, et al.Advances in Therapy|February 22, 2022
Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal MetabolizersAna Casajús, Pablo Zubiaur, Marta Méndez, et al.Frontiers in Pharmacology|November 1, 2024
Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokineticsEva González-Iglesias, Dolores Ochoa, Marcos Navares-Gómez, et al.British Journal of Clinical Pharmacology|April 7, 2020
The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple-dose trialDora Koller, Miriam Saiz-Rodríguez, Pablo Zubiaur, et al.Journal of Personalized Medicine|March 29, 2023
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy VolunteersMiriam Saiz-Rodríguez, Dolores Ochoa, Pablo Zubiaur, et al.Experimental Dermatology|September 28, 2018
Histone modifications associated with biological drug response in moderate-to-severe psoriasisMaría C Ovejero-Benito, Alejandra Reolid, Patricia Sánchez-Jiménez, et al.International Journal of Molecular Sciences|January 11, 2025
Effect of Genetic Variants on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Involvement of ABCG2, SLCO1B1 and NAT2Eva González-Iglesias, Clara Méndez-Ponce, Dolores Ochoa, et al.Pharmacogenomics|December 2, 2017
Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasisMaría C Ovejero-Benito, Rocío Prieto-Pérez, Mar Llamas-Velasco, et al.Journal of Personalized Medicine|November 25, 2023
Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and FinasterideGonzalo Villapalos-García, Pablo Zubiaur, Cristina Marián-Revilla, et al.Pageof 12